UK is first European country to see COVID-19 deaths pass 100,000More than 100,000 people have died within 28 days of a positive COVID-19 test in the UK, the Share XUK is first European country to see COVID-19 deaths pass 100,000https://pharmaphorum.com/news/uk-is-first-european-country-to-see-covid-19-deaths-pass-100000/
Nearly half of UK young people buy meds after consulting “Dr Google”It’s evident that relying on Google for a health diagnosis isn’t a good idea, but it seems a Share XNearly half of UK young people buy meds after consulting “Dr Google”https://pharmaphorum.com/news/nearly-half-of-uk-young-people-buy-meds-after-consulting-dr-google/
IL-6 drugs do work in COVID-19, says UK, as it plans NHS useNew data means that IL-6 drugs from Roche and Sanofi that had been all-but written off as coronavirus Share XIL-6 drugs do work in COVID-19, says UK, as it plans NHS usehttps://pharmaphorum.com/news/il-6-drugs-covid-19-new-trial/
UK parliament backs EU trade deal, as industry sifts through detailThe post-Brexit trade deal agreed on Christmas Eve has been overwhelmingly backed by the UK parliament, providing some Share XUK parliament backs EU trade deal, as industry sifts through detailhttps://pharmaphorum.com/news/uk-parliament-backs-eu-trade-deal-as-industry-sifts-through-detail/
VC fund dedicated to psychedelic meds launches in UKIn the last few years, biopharma companies focusing on psychedelic medicines have been springing up like mushrooms – Share XVC fund dedicated to psychedelic meds launches in UKhttps://pharmaphorum.com/news/vc-fund-dedicated-to-psychedelic-meds-launches-in-uk/
ABPI chief exec on the UK industry’s learnings from COVID-19The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 Share XABPI chief exec on the UK industry’s learnings from COVID-19https://pharmaphorum.com/views-analysis-market-access/abpi-chief-exec-on-the-uk-industrys-learnings-from-covid/
An introduction to the new NIHR National Patient Recruitment CentresA new network of patient recruitment centres is set to shape the future of commercial clinical trials in Share XAn introduction to the new NIHR National Patient Recruitment Centreshttps://pharmaphorum.com/r-d/views-analysis-r-d/an-introduction-to-the-new-nihr-national-patient-recruitment-centres/
Social media erupts as anti-vaxxers respond to COVID-19 vaccine approvalIn the midst of the jubilation about the UK’s emergency approval of Pfizer/BioNTech’s COVID-19 shot in the UK Share XSocial media erupts as anti-vaxxers respond to COVID-19 vaccine approvalhttps://pharmaphorum.com/news/social-media-erupts-as-anti-vaxxers-respond-to-covid-19-vaccine-approval/
UK groups get £12m funding for COVID-19 monitoring softwareResearchers at the Wellcome Sanger Institute in the UK are working on software to monitor the genome of Share XUK groups get £12m funding for COVID-19 monitoring softwarehttps://pharmaphorum.com/news/uk-groups-get-12m-funding-for-covid-19-monitoring-software/
